<code id='32293F4EFC'></code><style id='32293F4EFC'></style>
    • <acronym id='32293F4EFC'></acronym>
      <center id='32293F4EFC'><center id='32293F4EFC'><tfoot id='32293F4EFC'></tfoot></center><abbr id='32293F4EFC'><dir id='32293F4EFC'><tfoot id='32293F4EFC'></tfoot><noframes id='32293F4EFC'>

    • <optgroup id='32293F4EFC'><strike id='32293F4EFC'><sup id='32293F4EFC'></sup></strike><code id='32293F4EFC'></code></optgroup>
        1. <b id='32293F4EFC'><label id='32293F4EFC'><select id='32293F4EFC'><dt id='32293F4EFC'><span id='32293F4EFC'></span></dt></select></label></b><u id='32293F4EFC'></u>
          <i id='32293F4EFC'><strike id='32293F4EFC'><tt id='32293F4EFC'><pre id='32293F4EFC'></pre></tt></strike></i>

          Home / Wikipedia / knowledge

          knowledge


          knowledge

          author:entertainment    Page View:97962
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In